Alpine Associates Management Inc. Axonics, Inc. Transaction History
Alpine Associates Management Inc.
- $2.08 Billion
- Q2 2024
A detailed history of Alpine Associates Management Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Alpine Associates Management Inc. holds 2,108,871 shares of AXNX stock, worth $146 Million. This represents 6.8% of its overall portfolio holdings.
Number of Shares
2,108,871
Previous 1,814,771
16.21%
Holding current value
$146 Million
Previous $125 Million
13.27%
% of portfolio
6.8%
Previous 4.89%
Shares
2 transactions
Others Institutions Holding AXNX
# of Institutions
241Shares Held
42.8MCall Options Held
73.7KPut Options Held
230K-
Vanguard Group Inc Valley Forge, PA5.04MShares$350 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.34MShares$302 Million0.01% of portfolio
-
Fil LTD Hamilton, D02.04MShares$142 Million0.14% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.77MShares$123 Million2.93% of portfolio
-
Westchester Capital Management, LLC Valhalla, NY1.35MShares$93.9 Million3.73% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.41B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...